Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qiankunning Tablets vs Qingkailing Granules for Common Cold (Wind-Heat Pattern)
CTR20132600Phase 3Completed
- Sponsor
- Chengdu Enwei Pharmaceutical
- Start
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Qiankunning in nasopharyngitis, sponsored by Chengdu Enwei Pharmaceutical. Started Feb 2014; status: completed.
02
Drugs
Qiankunning
03
Conditions
nasopharyngitis
Beyond the preview
Go deeper on CTR20132600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132600.